An Update of Urine and Blood Metabolomics in Chronic Kidney Disease
Authors:
- 29 May 2019
- journal article
- review article
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 13 (7) , 577-596
Abstract
Chronic kidney disease is considered as a serious obstacle in global health, with increasing incidence and prevalence. In spite of numerous attempts by using recent omics technologies, specially me...Keywords
This publication has 169 references indexed in Scilit:
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylationKidney International, 2012
- Metabolomics: the apogee of the omics trilogyNature Reviews Molecular Cell Biology, 2012
- Genome-wide association study identifies multiple loci influencing human serum metabolite levelsNature Genetics, 2012
- Kynurenine is an endothelium-derived relaxing factor produced during inflammationNature Medicine, 2010
- Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolitesProceedings of the National Academy of Sciences of the United States of America, 2009
- Asymmetric dimethylarginine (ADMA)—A modulator of nociception in opiate tolerance and addiction?Nitric Oxide, 2007
- Mass spectrometry‐based metabolomicsMass Spectrometry Reviews, 2006
- Arginine, arginine analogs and nitric oxide production in chronic kidney diseaseNature Clinical Practice Nephrology, 2006
- Review on uremic toxins: Classification, concentration, and interindividual variabilityKidney International, 2003